ISP Holdings Limited (HKG:2340)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	98	98	102	108	323	149
Market Cap Growth	-4.17%	-4.17%	-5.88%	-66.45%	117.14%	6.06%
Enterprise Value	57	40	4	-157	235	172
Last Close Price	0.15	0.19	0.19	0.21	0.13	0.06
PE Ratio	-	-	-	0.29	16.46	10.46
PS Ratio	0.92	0.93	0.66	0.48	0.75	0.39
PB Ratio	0.65	0.65	0.55	0.54	1.96	1.02
P/TBV Ratio	0.69	0.69	0.58	0.56	2.06	1.08
P/FCF Ratio	-	-	-	-	-	0.91
P/OCF Ratio	-	-	-	-	-	0.89
EV/Sales Ratio	0.54	0.38	0.03	-	0.55	0.45
EV/FCF Ratio	-1.32	-	-	-	-	1.05
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.02	0.79
Debt / FCF Ratio	-	-	-	-	-	0.70
Asset Turnover	0.33	0.33	0.40	0.48	0.75	0.53
Quick Ratio	1.46	1.46	1.64	1.80	0.93	1.24
Current Ratio	2.01	2.01	2.12	1.89	1.46	1.26
Return on Equity (ROE)	-20.04%	-20.04%	-7.93%	-0.93%	-9.95%	-71.90%
Return on Assets (ROA)	-7.66%	-7.66%	-2.71%	-1.15%	-2.12%	-7.79%
Return on Capital (ROIC)	-14.68%	-14.68%	-5.41%	-2.94%	-5.69%	-20.08%
Earnings Yield	-34.40%	-34.32%	-14.95%	403.13%	6.07%	9.56%
FCF Yield	-44.21%	-44.12%	-24.05%	-15.18%	-2.45%	109.85%
Buyback Yield / Dilution	-	-	-	-	-	17.50%
Total Shareholder Return	-	-	-	-	-	17.50%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.